Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Menconi

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Journal of Endocrinological Investigation|June 29, 2017
Action of three bioavailable antioxidants in orbital fibroblasts from patients with Graves' orbitopathy (GO): a new frontier for GO treatment?G Rotondo Dottore, I Ionni, F Menconi, et al.
Journal of Endocrinological Investigation|August 27, 2022
Anti-nuclear autoantibodies in Graves' disease and Graves' orbitopathyG Lanzolla, L Puccinelli, M Giudetti, et al.
Journal of Endocrinological Investigation|October 28, 2004
Failure to use measurement of megalin secretory components complexed with serum thyroglobulin as a tool to identify metastases after surgery in papillary thyroid cancerS Lisi, F Menconi, M A Altea, et al.
Journal of Endocrinological Investigation|June 21, 2018
Relationship between serum cholesterol and Graves' orbitopathy (GO): a confirmatory studyG Lanzolla, E Sabini, M A Profilo, et al.
Journal of Endocrinological Investigation|January 19, 2015
Long-term outcome of Graves' orbitopathy following high-dose intravenous glucocorticoids and orbital radiotherapyE Sisti, F Menconi, M Leo, et al.
Journal of Endocrinological Investigation|August 23, 2018
Serum antibodies against the insulin-like growth factor-1 receptor (IGF-1R) in Graves' disease and Graves' orbitopathyM Marinò, G Rotondo Dottore, I Ionni, et al.
Journal of Endocrinological Investigation|July 29, 2016
Statins are not a risk factor for liver damage associated with intravenous glucocorticoid pulse therapy for Graves' orbitopathyE Sabini, E Sisti, B Coco, et al.
Journal of Endocrinological Investigation|September 1, 2017
Use of low-dose radioiodine ablation for Graves' orbitopathy: results of a pilot, perspective study in a small series of patientsM Leo, E Sabini, I Ionni, et al.
Journal of Endocrinological Investigation|October 21, 2021
Role of the mononuclear cell infiltrate in Graves' orbitopathy (GO): results of a large cohort studyG Rotondo Dottore, L Torregrossa, G Lanzolla, et al.
Journal of Endocrinological Investigation|June 1, 2020
Asymmetry indicates more severe and active disease in Graves' orbitopathy: results from a prospective cross-sectional multicentre studyP Perros, M P Žarković, G C Panagiotou, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Journal of Endocrinological Investigation|June 29, 2017
Action of three bioavailable antioxidants in orbital fibroblasts from patients with Graves' orbitopathy (GO): a new frontier for GO treatment?G Rotondo Dottore, I Ionni, F Menconi, et al.
Journal of Endocrinological Investigation|August 27, 2022
Anti-nuclear autoantibodies in Graves' disease and Graves' orbitopathyG Lanzolla, L Puccinelli, M Giudetti, et al.
Journal of Endocrinological Investigation|October 28, 2004
Failure to use measurement of megalin secretory components complexed with serum thyroglobulin as a tool to identify metastases after surgery in papillary thyroid cancerS Lisi, F Menconi, M A Altea, et al.
Journal of Endocrinological Investigation|June 21, 2018
Relationship between serum cholesterol and Graves' orbitopathy (GO): a confirmatory studyG Lanzolla, E Sabini, M A Profilo, et al.
Journal of Endocrinological Investigation|January 19, 2015
Long-term outcome of Graves' orbitopathy following high-dose intravenous glucocorticoids and orbital radiotherapyE Sisti, F Menconi, M Leo, et al.
Journal of Endocrinological Investigation|August 23, 2018
Serum antibodies against the insulin-like growth factor-1 receptor (IGF-1R) in Graves' disease and Graves' orbitopathyM Marinò, G Rotondo Dottore, I Ionni, et al.
Journal of Endocrinological Investigation|July 29, 2016
Statins are not a risk factor for liver damage associated with intravenous glucocorticoid pulse therapy for Graves' orbitopathyE Sabini, E Sisti, B Coco, et al.
Journal of Endocrinological Investigation|September 1, 2017
Use of low-dose radioiodine ablation for Graves' orbitopathy: results of a pilot, perspective study in a small series of patientsM Leo, E Sabini, I Ionni, et al.
Journal of Endocrinological Investigation|October 21, 2021
Role of the mononuclear cell infiltrate in Graves' orbitopathy (GO): results of a large cohort studyG Rotondo Dottore, L Torregrossa, G Lanzolla, et al.
Journal of Endocrinological Investigation|June 1, 2020
Asymmetry indicates more severe and active disease in Graves' orbitopathy: results from a prospective cross-sectional multicentre studyP Perros, M P Žarković, G C Panagiotou, et al.
Pageof 3